Diabetes drug Ozempic is not approved for weight loss, but this trend is leaving diabetics without
University of Sydney Associate Lecturer Pharmacy Practice Andrew Bartlett joins the program to explain the rising use of this diabetes drug by Australian consumers looking to lose weight and the dangers associated with it. Dan and Andrew talk about how this rise is seeing shortages for diabetics in need of it and what regulators need to do to address this issue.
Download this podcast here